Townsend Richard Nolan (CIK 1995218) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-19). Recent activity: Sell LXEO (3,345 shares), Buy LXEO (67,000 shares), Sell LXEO (25,947 shares), Sell LXEO (3,342 shares), Sell LXEO (55,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 3,345 | $16,562 |
| 2026-07-01 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Buy | 67,000 | $0 |
| 2026-07-01 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 25,947 | $116,243 |
| 2026-05-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 3,342 | $16,927 |
| 2026-04-07 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 55,000 | $313,137 |
| 2026-03-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Buy | 2,623 | $6,925 |
| 2026-02-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 10,173 | $64,904 |
| 2026-02-06 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Buy | 161,665 | $0 |
| 2025-11-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 1,127 | $10,447 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Buy | 33,000 | $0 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 12,985 | $116,086 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 148 | $1,415 |
| 2025-09-16 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Buy | 2,193 | $5,790 |
| 2025-09-10 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 1,115 | $5,207 |
| 2025-08-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 2,735 | $12,772 |
| 2025-05-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Sell | 1,074 | $2,975 |
| 2025-04-01 | Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer | Buy | 2,128 | $5,554 |
Source: SEC Form 4 filings · as of 2026-08-19